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Abstract-  A  comparative  evaluation  of  the  antidiabetic  and 
hypoglycaemic potential of the extracts from different plant parts 
of Musa paradisiaca (MP) was carried out in vitro. MP extracts 
were  prepared  sequentially  with  methanol,  chloroform  and 
petroleum ether.  A comparison was made between the action of 
extracts  from  different  parts.  Different  concentrations  of  each 
extract were made by using phosphate buffer and subjected to α-
amylase and α-glucosidase inhibitory assays using maltose and 
2-Chloro-4-Nitrophenyl-α-Maltotrioside  as  substrates 
respectively.  Using  this  method,  the  percentage  of  α-amylase 
inhibitory activities of each extract were calculated. The enzymes 
were extracted from the sheep intestines. The absorbencies ware 
read at 595 nm and 405nm respectively using spectrophotometer. 
Methanol extracts were found to show higher inhibition. It was 
found that fruit and stem extract showed high rate of inhibition. 
At 100 μg/ml concentration of the stem extract a high of 83% 
inhibition of α-amylase was recorded. A high of 80% inhibition 
was recorded for α-glucosidase activity when 100 μg/ml of stem 
extrats were used. Leaf and flower extracts were also good in the 
inhibition of both the enzymes but the rate of inhibition was vey 
less and at 100 μg/ml concentration the rate of inhibition was 
18%. The results conclusively provide proof that MP extracts are 
andidiabetic  by  being  hypoglycaemic.  The  results  strongly 
recommend  the  use  of  banana  extracts  in  the  control  and  the 
treatment of type-2 diabetic mellitus. 
 
Index Terms- Musa paradisiaca, antidiabetic, diabetic mellitus, 
hypoglycaemic 
 
I.  INTRODUCTION 
iabetes  is  a  serious  metabolic  disorder  affecting  the 
metabolism of not only carbohydrate but also protein and 
fat.  A number of studies have shown that diabetes  mellitus is 
associated  with  oxidative  stress,  leading  to  an  increased 
production of reactive oxygen species. It is a metabolic disease 
characterized  by  hyperglycemia  and  disturbances  in  fat  and 
protein  metabolism  that  results  from  defects  in  both  insulin 
secretion and/or insulin action (Teixeira et al, 2000). Type 2 is 
more associated with an adulthood and elderly people, which are 
mainly due to insulin resistance or abnormal insulin secretion. 
The exact causes of pancreatic failure and insulin resistance not 
clearly  known,  but  they  are  associated  with  disease  state, 
environmental impact and food habit. Diabetic patients are more 
susceptible to various type of infections such as skin diseases and 
carbuncles (Warjeet Singh, 2011).  The prevalence of diabetes 
mellitus  is  increasing  worldwide,  associated  with  the  aging 
population  and  the  epidemiological  transition  (Yusuf,  et  al, 
2001). It is estimated that by 2030, 366 million individuals will 
be affected by the disease worldwide, being 11.3 million living in 
Brazil  where  this  would  represent  an  increase  of  almost  three 
times the number of individuals with the disease today (Wild et 
al, 2000). India accounts for the largest number of people (50.8 
million) suffering from diabetes in the world, followed by China 
(43.2 million) and the United States (26.8 million). This is based 
the  figures  released  by  the  International  Diabetes  Federation 
(IDF). The onset and progression of long-term complications in 
diabetes  mellitus  appear  to  be  related  to  the  degree  of 
hyperglycemia  and  the  overall  metabolic  control.  It  is  highly 
beneficial to identify the traditional herbal drugs which might be 
useful  in  controlling    diabetes  and  play  a  role  preventing  or 
mitigating cellular damages related to diabetes. It is advisable to 
use  plant  based  inhibitors  of  α-amylase  and  α-glucosidase 
enzymes  that  participate  in  the  breakdown  of  polysaccharides 
into disaccharides and monosaccharides in the intestine. Which 
in turn lead to hyperglycemia, one of the major complication of 
type-2  diabetic  mellitus.  It  has  been  shown  that  activity  of 
pancreatic  α-amylase  in  the  small  intestine  correlates  to  an 
increase in postprandial glucose levels, the control of which is 
therefore  an  important  aspect  in  treatment  of  type-2  diabetes 
(Kim, et al, 2005 and Matsui et al, 1996). Inhibitors of pancreatic 
α-amylase delay carbohydrate digestion causing a reduction in 
the  rate  of  glucose  absorption  and  lowering  the  postprandial 
serum glucose levels. Pancreatic α-amylase is a key enzyme in 
the digestive system and catalyses the initial step in hydrolysis of 
starch  to  a  mixture  of  smaller  oligosaccharides  consisting  of 
maltose,  maltotriose,  and  a  number  of  α-(l-6)  and  α-(1-4) 
oligoglucans. These are then acted on by alpha glucosidases and 
further degraded to glucose that on absorption enters the blood 
stream.  Plantains  are  a  good  source  of  vitamin  A  (carotene),  
vitamin  B  complex  (thiamin  b,  niacin  riboflavin  and  B6)  and  
vitamin  C  (ascorbic  acid).  Musa  paradisiaca  (Musaceae)  is 
widely distributed throughout the tropical regions. It is a plantain 
and  a  tall  herb  with  aerial  pseudostem  dying  after  flowering. 
Fruits are produced several clusters and are golden yellow colour 
on ripening. Plantains provide a better source  of vitamin A than 
most other staples (Aurand, 1987). Plantain is employed in the 
folklore  management  of    diseases  such  as  diabetes,  ulcer  and 
wound healing due to  its hypoglycaemic, anti-ulcerogenic and 
analgesic  properties (Bischoff, 1994). Earlier report on the role 
of green plantain products in the control of hyperglycaemia  had 
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been discussed  (Oboh and Erema, 20 10, Willet et al., 2002). 
The stem juices of Musa paradisiaca have been used in treatment 
of diabetes mellitus as claimed in literature (Vedamurthy et al, 
1997). Hence the present study was focused on investigating the 
antidiabetic potential of plantain. The study was also aimed at 
investigating  the  exact  part  the  plant  which  is  having  high 
potential  in  controlling  diabetes.  These  studies  will  provide  a 
more  in  depth  picture  on  the  potential  of  this  interesting 
traditional and widely consumed tropical fruit. 
 
II.  MATERIALS AND METHODS 
        Preparation  of  plant  extract:  Plantain  variety  of  Musa 
paradisiaca (MP) which is a commercially cultivated was used 
in the present study. The plant materials (Fig.1) were procured 
from  the  local  growers.  Extraction  was  carried  using  flowers, 
leaves, pseudostems and unripe fruits. The samples were minced 
into fine paste using manual grinder sterilized with  77% ethanol. 
The  extraction  was  done    using  soxhlet  extraction  method  as 
described in  AOAC (1980). Extraction set-up  left for twelve 
hours after which the extract  was recovered by using different 
solvents  such  as,  chloroform,  methanol  and  petroleum  ether 
separately.  The  extracts  were  glass  evaporated    by  rotary 
evaporator and a thick paste was obtained as homogenate It was  
used as the sample.  
 
   
 
Fig-1: Musa paradisiaca flowering and pseudostem used in the experiment 
 
        Preparation  of  enzymes:  Small  intestines  of  sheep  were 
procured  from  the  local  market  freshly  and  stored  in  cold 
condition.  The  fresh  intestine  was  cut  into  small  pieces  and 
macerated  in  chill  conditions  using  phosphate  buffer  and  then 
finely grinded into smooth paste (homogenate). The paste was 
centrifuged  in  refrigerated  centrifuge  at  10,000rpm.  The  clear 
solution obtained as the supernatant was used as the source of α-
amylase and α-glucosidase.  
 
Inhibition of α-amylase: 
        The fresh intestine was cut into small pieces and macerated 
in chill conditions using phosphate buffer and then finely grinded 
it into smooth homogenate. The homogenate prepared from small 
intestine of sheep was used as enzyme source. Final volume of 
supernatant  was  maintained  to  20%  (w/v).  Here,  40  μl  tissue 
homogenate was mixed with 80 μl of test standard plant extract 
and incubated for 15 min at 37°C. Then, 280 μl maltose (37 mM) 
was  added  as  the  substrate  for  the  enzymatic  activity.  The 
reaction  mixture  was  incubated  for  30  min.  ultimately,  the 
enzymatic reaction was stopped by putting the tubes in boiling 
water for 10 min. Later, the tubes were centrifuged and glucose 
concentration  was  assessed  in  the  supernatant  by  glucose 
oxidase/presence of peroxidase method based kit. Readings (OD) 
were  taken  in  the  spectrophotometer.  Standard 
spectrophotometric  assay  method  with  slight  modification 
(Kajaria, et al, 2011) was used. The absorbencies were read at 
595 to record the rate of inhibition of α-amylase.  
 
Inhibition of α-glucosidase: 
        Readings  (OD)  were  taken  in  the  spectrophotometer. 
Standard spectrophotometric assay method (Kumar et al, 2011) 
was used by slightly modifying the original procedure. The 90 μl 
of homogenate-supernatant  was  mixed  with 180 μl of 40  mM 
phosphate buffer (pH 6.9), plant extract, and positive control of 
various concentrations and incubated at 37°C for 15 min. To this 
reaction mixture, 360 μl of substrate, 2-Chloro-4-Nitrophenyl-α-
Maltotrioside (CNPG  3- 0.5 mg/ml) was added, mixed and for 
incubated 37°C for 10 min. Finally, absorbance was measured at 
405 nm against blank in spectrophotometer. A control reaction 
was carried out without the test sample.The enzyme inhibitory 
rates of samples were calculated as follows:  
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III.  RESULTS 
        There are a number of plants that show antidiabetic property 
but  in  this  study  MP  was  used  mainly  because  it  is  widely 
consumed as a vegetable in tropical regions. MP extracts were 
prepared sequentially with methanol, chloroform and petroleum 
ether.  Out  of  these  four  extracts  only  the  methanol  extracts 
obtained  through  were  found  to  give  good  rate  of  inhibition. 
Hence all the further studies and analyses were carried out using 
only  the  methanol  extracts.  Four  different  MP  extracts  were 
tested for the inhibition of the α-amylase (Table-1, Figs-2 and 4) 
and α-glucosidase (Table-2, Figs-3 and 5) enzymes. 10 μg/ml to 
100 μg/ml range of MP extracts were only used for final analysis 
as  after  100  μg/ml  concentration  there  was  decline  in  the 
inhibition rate. It was found that fruit and stem extract showed 
high rate of inhibition. At 100 μg/ml concentration of the stem 
extract a high of 83% inhibition of α-amylase was recorded. A 
high of 80% inhibition was recorded for α-glucosidase activity 
when  100  μg/ml  of  stem  extrats  were  used.  Leaf  and  flower 
extracts were also good in the inhibition of both the enzymes but 
the rate of inhibition was very less. At 100 μg/ml concentration 
the rate of inhibition was 18%. The results conclusively proved 
that MP extracts are andidiabetic by being hypoglycaemic. 
 
  10 
μg/ml 
20 
μg/ml 
30 
μg/ml 
40 
μg/ml 
50 
μg/ml 
60 
μg/ml 
70 
μg/ml 
80 μg/ml  90 
μg/ml 
100 
μg/ml 
STEM  2  8  24  34  45  62  71  73  81  83 
FRUIT  1  9  27  45  53  60  68  72  74  76 
LEAF  0  0  05  09  15  16  16  17  18  18 
FLOWER  0  0  0  0  7  9  12  12  13  14 
 
Table-1: Percentage of inhibition by MP extracts. Different concentrations of methanol extracts were used to inhibit the 
activity of α-amylase enzyme obtained from the small intestine of sheep. 
 
  10 
μg/ml 
20 
μg/ml 
30 
μg/ml 
40 
μg/ml 
50 
μg/ml 
60 
μg/ml 
70 
μg/ml 
80 μg/ml  90 
μg/ml 
100 
μg/ml 
STEM  0  8  14  24  33  52  61  64  79  80 
FRUIT  0  6  18  35  43  46  58  62  68  69 
LEAF  0  0  0  5  11  13  19  19  21  21 
FLOWER  0  0  0  0  3  7  8  12  12  13 
 
Table-2: Percentage of inhibition by MP extracts. Different  concentrations  of methanol extracts were used to inhibit the 
activity of α-glucosidase enzyme obtained from the small intestine of sheep. 
 
IV.  DISCUSSION 
        Diabetes  mellitus,  a  common  heterogeneous  metabolic 
syndrome,  is  prevalent  throughout  the  world  and  has  been 
projected to become one of the world's main disablers and killers 
within the next 25 years. Blood glucose level, urine sugar and 
body  weight  have  been  commonly  measured  to  monitor  the 
glycemic  control  mechanism.  Several  authors  reported 
flavonoids,  sterols,  alkaloids  and  polyphenols  as  bioactive 
antidiabetic  principles  (Ojewole  and  Adewunmi,  2003).  The 
result  of  phytochemical  screening  on  the  stem  juice  of  M. 
paradisiaca  reveals  that  the  extract  contained  various 
pharmacologically  active  compounds  such  as  tannins  and 
alkaloids. There are several studies reported positive correlation 
between  phenolic  content  of  plants  and  their  respective 
antidiabetic activities (Anam et al, 2009 and Momo et al, 2009). 
Currently  available  oral  therapies  for  treatment  of  diabetes 
mellitus are sulfonylureas, biguanides, α-glucosidase inhibitors, 
and glinides, which can be used alone or combined with other 
drugs to achieve better effect. Many of these oral antidiabetic 
agents  have  a  number  of  serious  adverse  effects,  thus,  the 
management  of  diabetes  without  any  side  effects  is  still  a 
challenge  (Sharma  et  al,  2009).  Plants  like  Musa  paradisiaca 
containing  natural  antioxidants  such  as  tannins,  flavonoids, 
vitamin  C  and  E  can  preserve  β-cell  function  and  prevent 
diabetes  induced  ROS  formation.  Polyphenols,  which  are 
classified  into  many  groups  such  as  flavonoids,  tannins  and 
stilbenes, have been known as health-beneficial properties, which 
include  free  radical  scavenging,  inhibition  of  hydrolytic  and 
oxidative  enzymes,  anti-inflammatory  action  and 
antidiabetogenic  potentiality.  Natural  anti-diabetic  drugs  from 
medicinal plants, are the other available therapy for the treatment 
of diabetse mellitus due to their well-known biological activity. 
Substances extracted from fruiting bodies, cultured mycelia, and 
culture  media  have  exhibited  promising  in  vitro  and  in  vivo 
biological activity including anti-diabetes (Lu et al, 2010). The 
ethnobotanical information reports a huge number of plants that 
may  possess  anti-diabetic  potential,  of  which  Momordica 
charantia  (M.  charantia),  Pterocarpus  marsupium  (P. 
marsupium), and Trigonella foenum (T. foenum) greacum have 
been reported to be beneficial for treatment of type 2 diabetes. 
Herbal treatments for diabetes have been used in patients with 
insulin dependent and non-insulin dependent diabetes, diabetic 
retinopathy, diabetic neuropathy etc. The families of plants with 
the  most  potent  hypoglycaemic  effects  include  Leguminoseae, 
Lamiaceae,  Liliaceae,  Cucurbitaceae,  Asteraceae,  Moraceae, 
Rosaceae, Euphorbiaceae and Araliaceae (Bnouham  et al, 2006). 
This indicates that there are many plants that can be used as drug 
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than  the  synthetic  drugs  which  will  have  severe  side  effects. 
There are a number of plants that show antidiabetic property but 
in this study MP was used mainly because it is widely consumed 
as a vegetable in tropical regions.  In the current investigation we 
found  that  some  parts  of  plantain,  like  fruit  and  stem  were 
extremely  good  in  inhibiting  the  enzymes.  They  showed  80% 
inhibition at certain concentrations. Thus these finding support 
the fact that   Musa paradisiacal is a source of potential drug 
against diabetes. This is the reason probably in India traditionally 
people have been eating food on plantain leaf. Our results show 
that  the  all  most  all  part  of  the  plantain  were  successful  in 
inhibiting  the  two  most  important  intestinal  enzymes  that 
regulate blood sugar level.  
 
   
 
 
 
Figs. 2,3,4,5: Percentage of inhibition by MP extracts. Different concentrations of methanol extracts were used to inhibit the 
activity of enzymes obtained from the small intestine of sheep. Fig-2 and 4 indicate the inhibition of α-amylase and Fig-3 and 5 
indicate the inhibition of α Glucosidase. 
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